Travaux scientifiques

Prof. Dr. Meral Beksaç

912 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Outcome is worse in male compared to female de novo AML patients and can be improved with the use of granulocyte colony stimulating factor(G-CSF) during induction.: Results of a randomized multicentric Trial(Turkish leukemia study group (TLG95-002)

    Blood, 2002

    Source : ORCID

  2. Presence of CMV DNA in blood is a predictor of shorter survival following both allogeneic bone marrow and peripheral stem cell transplantation

    Bone Marrow Transplantation, 2002

    Source : ORCID

  3. The choice between bone marrow versus peripheral blood for patients undergoing allogeneic transplant for AML 1CR should be based on the marrow cell dose - A survey of EBMT since 1994

    Bone Marrow Transplantation, 2002

    Source : ORCID

  4. The profile of erythrocyte antigens after allogeneic hematopoietic stem cell transplantation

    Bone Marrow Transplantation, 2002

    Source : ORCID

  5. The role of ABO incompatibility in allogeneic peripheral blood stem cell transplantation

    Turkish Journal of Haematology, 2002

    Source : ORCID

  6. The role of busulfan at post transplant pulmonary complications in allogeneic hematopoietic cell transplantation

    Bone Marrow Transplantation, 2002

    Source : ORCID

  7. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia

    Blood, 2002

    DOI 10.1182/blood-2001-12-0304 PMID 12130483 175 citations (Europe PMC) Source : ORCID

  8. Maternal Kanda Fetal Hücreler ve DNA

    Turkiye Klinikleri Journal of Gynecology and Obstetrics, 2002

    Source : OpenAlex

  9. Automated contour detection in blood cell images by an efficient snake algorithm

    Nonlinear Analysis, 2001

    DOI 10.1016/s0362-546x(01)00707-6 18 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  10. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies

    Cytotherapy, 2001

    DOI 10.1080/146532401317070880 PMID 12171713 6 citations (Europe PMC) Source : ORCID

  11. Allogeneic hematopoietic stem cell transplantation using IV Busulfan

    Blood, 2001

    Source : ORCID

  12. Allogeneic peripheral blood stem cell transplantation for severe aplastic anemia

    Therapeutic Apheresis, 2001

    DOI 10.1046/j.1526-0968.2001.005001054.x PMID 11258612 3 citations (Europe PMC) Source : ORCID

  13. An automated differential blood count system

    Annual Reports of the Research Reactor Institute, Kyoto University, 2001

    Source : ORCID

  14. Application of interphase FISH for molecular monitoring of patients transplanted with non-myeloablative conditioning

    Bone Marrow Transplantation, 2001

    Source : ORCID

  15. CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation

    Journal of Clinical Apheresis, 2001

    DOI 10.1002/jca.1015 PMID 11746531 15 citations (Europe PMC) Source : ORCID

  16. Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: An EORTC- HOVON randomized phase III study (06914)

    British Journal of Haematology, 2001

    DOI 10.1046/j.1365-2141.2001.03171.x PMID 11843823 64 citations (Europe PMC) Source : ORCID

  17. Frequent demonstration of human herpesvirus 8 (HHV-8) in bone marrow biopsy samples from Turkish patients with multiple myeloma (MM)

    Leukemia, 2001

    DOI 10.1038/sj.leu.2402190 PMID 11480570 8 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  18. Hematopoietic cell transplantation-related nephropathy [2] (multiple letters)

    American Journal of Kidney Diseases, 2001

    DOI 10.1053/ajkd.2001.26163 PMID 11431209 3 citations (Europe PMC) Source : ORCID

  19. Perturbation of p16 and p21 expression is observed in chronic myelogenous leukemia (CML) and multiple myeloma (MM) while cyclins A, B, D and E patterns are generally conserved. A flow cytometric analysis

    Blood, 2001

    Source : ORCID

  20. Probability of finding a HLA identical related bone marrow donor approaches 1:2 in a Turkish registry. Roles of donor bone marrow & cord blood registry and extended family search

    European Journal of Immunogenetics, 2001

    Source : ORCID

  21. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation

    Bone Marrow Transplantation, 2001

    DOI 10.1038/sj.bmt.1702816 PMID 11313683 22 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  22. Telomerase activity in hematologic malignancies and predisposing diseases

    Turkish Journal of Haematology, 2001

    Source : ORCID

  23. The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation

    Transfusion and Apheresis Science, 2001

    DOI 10.1016/s0955-3886(00)00123-5 PMID 11515607 8 citations (Europe PMC) Source : ORCID

  24. The incidence of avascular necrosis of the femoral head after allogeneic hematopoietic stem cell transplantation

    Bone Marrow Transplantation, 2001

    Source : ORCID

  25. The long term follow-up of lymphoma patients conditioned with CBV regimen and autologous stem cell rescue:: Ibni Sina experience

    Bone Marrow Transplantation, 2001

    Source : ORCID

  26. The role of allogeneic hematopoietic cell transplantation with non-myeloablative conditioning in chronic myeloid leukemia

    Blood, 2001

    Source : ORCID

  27. Transplant Related Mortality (TRM) after allogeneic transplant is considerably higher after 35 years of age. Background investigation for designing studies based on reduced conditioning regimens

    Bone Marrow Transplantation, 2001

    Source : ORCID

  28. Treatment of steroid refractory GVHD with anti-thymocyte globulin

    Bone Marrow Transplantation, 2001

    Source : ORCID

  29. A randomised study from the European Group for Blood and Marrow Transplantation comparing allogeneic transplantation of filgrastim-mobilised peripheral blood progenitor cells with bone marrow transplantation in 350 patients (pts) with leukemia

    Blood, 2000

    Source : ORCID

  30. Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: Experience of Ibni Sina Hospital

    Bone Marrow Transplantation, 2000

    DOI 10.1038/sj.bmt.1702414 PMID 10871726 2 citations (Europe PMC) Source : ORCID

  31. Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-α-2a treatment

    Cancer, 2000

    Source : ORCID

  32. Human herpesvirus 8 open reading frame 26 and open reading frame 65 sequences from multiple myeloma patients: A shared pattern not found in Kaposi's sarcoma or primary effusion lymphoma

    Clinical Cancer Research, 2000

    PMID 11106236 12 citations (OpenAlex) Source : ORCID

  33. Increased telomerase activity (TA) in CD38+CD138+bone marrow mononuclear cells (BMMCs) from multiple myeloma (MM) patients

    Blood, 2000

    Source : ORCID

  34. Soluble adhesion molecules (sICAM-1, sL-Selectin, sE-Selectin, sCD44) in healthy allogenic peripheral stem-cell donors primed with recombinant G-CSF

    Cytotherapy, 2000

    DOI 10.1080/146532400539198 PMID 12042035 7 citations (Europe PMC) Source : ORCID

  35. The value of peripheral blood CD34+ cell quantification in autologous hematopoietic stem cell apheresis

    Blood, 2000

    Source : ORCID

  36. Thrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis

    Acta Haematologica, 2000

    DOI 10.1159/000041038 PMID 10940653 47 citations (Europe PMC) Source : ORCID

  37. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: A focus on the incidence of graft-vs.-host disease and relapse

    Biology of Blood and Marrow Transplantation, 1999

    DOI 10.1053/bbmt.1999.v5.pm10232738 PMID 10232738 27 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  38. Adoptive immunity transfer in hepatitis B virus carriers with hematological malignancy who undergoing allogeneic hematopoietic stem cell transplantation

    Hepatology, 1999

    Source : ORCID

  39. All-trans retinoic acid(Atra) in addition to R-interferon alpha in cml in first chronic phase, a feasibility study by the EORTC-LCG

    Blood, 1999

    Source : ORCID

  40. Allogeneic hematopoietic cell transplantation in patients with advanced hematological malignancies by using nonmyeloablative conditioning regimen

    Bone Marrow Transplantation, 1999

    Source : ORCID

  41. Allogeneic peripheral blood stem cell transplantation in patients with severe aplastic anemia

    Blood, 1999

    Source : ORCID

  42. Analysis of tissue factor (TF) expression on leukemic cells by flow cytometry: Correlation with tissue factor activity and clinical parameters

    Thrombosis and Haemostasis, 1999

    Source : ORCID

  43. Chronic graft-versus-host disease complicated by membranous glomerulonephritis

    Nephrology Dialysis Transplantation, 1999

    DOI 10.1093/ndt/14.10.2461 PMID 10528673 36 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  44. Clinical effects of intravenous immune globulin (IVIG) treatment in patients with allogeneic peripheral stem cell transplantation

    Blood, 1999

    Source : ORCID

  45. Differences in liver pathology and clinical outcome between two patients with Hepatitis B virus and graft versus host disease

    Pathology and Oncology Research, 1999

    DOI 10.1053/paor.1999.0229 PMID 10491023 1 citation (Europe PMC) Source : ORCID

  46. Frequencies of HLA DRB1 allel haplotype frequencies in a Turkish registry of bone marrow donors by low resolution typing

    Bone Marrow Transplantation, 1999

    Source : ORCID

  47. Hematopoietic stem cell transplantation from non-replicative hepatitis B virus carriers is safe

    Journal of Hepatology, 1999

    DOI 10.1016/s0168-8278(99)80214-1 PMID 10453930 4 citations (Europe PMC) Source : ORCID

  48. Identification of a myeloma specific HHV-8ORF65 gene.

    Blood, 1999

    Source : ORCID

  49. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma [2]

    Cancer, 1999

    DOI 10.1002/(sici)1097-0142(19990101)85:1<242::aid-cncr34>3.0.co;2-r PMID 9921999 Source : ORCID

  50. Surface adhesion molecules in peripheral stem cells of healthy donors primed with G-CSF

    Bone Marrow Transplantation, 1999

    Source : ORCID